by Shahbaz Syed | Jun 1, 2023 | Commentary, Featured
Well, the CAEP 2023 (#CAEP23) (Canadian Associated of Emergency Physicians) conference is officially over. We’ve head back to our respective homes and departments, and by now the melancholy has fully kicked in. It was the first time, in a while, that the CAEP...
by Shahbaz Syed, Hans Rosenberg | Sep 13, 2021 | Commentary, Featured
1 Million views! Holy smokes. It feels like just yesterday (September 2017 to be more accurate) that we set up the EMOttawa Blog here, with the goal of spreading Digital Scholarship and Knowledge Dissemination in the spirit of #FOAMed, with some of the incredible...
by Mikki McGuinty, Rajiv Thavanathan, James Gilbertson | Sep 9, 2021 | Featured, Infectious Disease, Podcast
Listen on Apple PodcastsListen on SpotifyListen on Google PodcastsListen on Stitcher EMOttawa Podcast Episode 6Tick Borne Illness Part 2 – Anaplasmosis (Click here to access Podcast Main menu) Click here for Part 1, focusing on Lyme disease. In part 2 of our...
by Meredith Hall | Jun 24, 2021 | EDI, Featured
Dr. Jason McVicar was born in the Northwest Territories and is of French Metis descent. He spent part of his childhood in the Northwest Territories, but moved to Manitoba, where most of his family was (and many remain), when his father was transferred there for his...
by Michael Wong, Alex Coutin | Aug 13, 2020 | Featured
1. If your patient fits DSM5 diagnostic criteria for alcohol withdrawal: NALTREXONE GABAPENTIN Naltrexone 25mg PO daily x 4d, then 50mg PO daily ~$2.81 per pill, or LU code 532 if on Ontario Drug Benefit/ODSP Contraindications: – Liver disease (LFTs...
